Linda L. Kusner - Concepedia

Author

Linda L. Kusner

Also Known As

Kaminski, Henry J., L KUSNER, L Kusner, L L Kusner, L. L. Kusner, LINDA KUSNER, LINDA L. KUSNER, Linda Kusner, Linda L Kusner, Linda L. Kusner

Publications

1.8K

Citations

H-Index

Concepts

All Affiliations

George Washington University Case Western Reserve University University Hospitals of Cleveland University School Saint Louis University

About

Linda L. Kusner is an author at George Washington University specializing in medicine, immunology, and physiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	13	530
2	Allergy	5	5	185
3	Health Sciences	3	3	132
4	Natural Sciences	1	1	20
5	Social Sciences	1	1	13

Linda L. Kusner

Publications

1.3K

Citations

H-Index

Page 1

	Year	Citations
Novel complement inhibitor limits severity of experimentally myasthenia gravis Jindřich Šoltýs, Linda L. Kusner, Andrew Young, Annals of Neurology	2009	92
Nitric oxide synthase is concentrated at the skeletal muscle endplate Linda L. Kusner, Henry J. Kaminski Brain Research BiosynthesisMolecular PhysiologyCellular EnzymologyBiochemistryReactive Nitrogen Specie	1996	89
Expression of acetylcholine receptor isoforms at extraocular muscle endplates. Henry J. Kaminski, Linda L. Kusner, Christine H. Block PubMed	1996	78
Constitutive properties, not molecular adaptations, mediate extraocular muscle sparing in dystrophic <i>mdx</i> mice John D. Porter, Anita P. Merriam, Sangeeta Khanna, The FASEB Journal	2003	77
<i>Extraocular Muscle Susceptibility to Myasthenia Gravis</i> Jindřich Šoltýs, Bendi Gong, Henry J. Kaminski, Annals of the New York Academy of Sciences Muscle FunctionImmunologyAnatomyOther Skeletal MuscleInflammation	2008	76
Standardization of the experimental autoimmune myasthenia gravis (EAMG) model by immunization of rats with Torpedo californica acetylcholine receptors — Recommendations for methods and experimental designs Mario Losen, Pilar Martínez‐Martínez, Peter Molenaar, Experimental Neurology B Cell SelectionAcetylcholine ReceptorsAutoimmune DiseaseAllergyVoluntary Muscles	2015	64
Myeloid-Derived Suppressor Cells as a Potential Therapy for Experimental Autoimmune Myasthenia Gravis Yan Li, Zhidan Tu, Shiguang Qian, The Journal of Immunology	2014	61
Deficiency of decay accelerating factor and CD59 leads to crisis in experimental myasthenia Henry J. Kaminski, Linda L. Kusner, Chelliah Richmonds, Experimental Neurology PhysiologyExperimental MyastheniaMolecular BiologyPathology	2006	57
Susceptibility of Ocular Tissues to Autoimmune Diseases Henry J. Kaminski, Zhuyi Li, Chelliah Richmonds, Annals of the New York Academy of Sciences	2003	52
Investigational RNAi Therapeutic Targeting C5 Is Efficacious in Pre-clinical Models of Myasthenia Gravis Linda L. Kusner, Kristina Yucius, Manjistha Sengupta, Molecular Therapy — Methods & Clinical Development	2019	52

Page 1